Corvus Pharma Raises $75M To Help Cancer Treatment R & D
Corvus Pharmaceuticals, which is attempting to develop immuno-oncology treatments for patients with cancer, said on Tuesday that it has closed a $75 million round of financing, the proceeds of which will...To view the full article, register now.
Already a subscriber? Click here to view full article